Ontology highlight
ABSTRACT: Background
Cardiac implantable electronic device (CIED) implantation rates as well as the clinical and procedural characteristics and outcomes in patients with known active coronavirus disease 2019 (COVID-19) are unknown.Objective
The purpose of this study was to gather information regarding CIED procedures during active COVID-19, performed with personal protective equipment, based on an international survey.Methods
Fifty-three centers from 13 countries across 4 continents provided information on 166 patients with known active COVID-19 who underwent a CIED procedure.Results
The CIED procedure rate in 133,655 hospitalized COVID-19 patients ranged from 0 to 16.2 per 1000 patients (P <.001). Most devices were implanted due to high-degree/complete atrioventricular block (112 [67.5%]) or sick sinus syndrome (31 [18.7%]). Of the 166 patients in the study survey, the 30-day complication rate was 13.9% and the 180-day mortality rate was 9.6%. One patient had a fatal outcome as a direct result of the procedure. Differences in patient and procedural characteristics and outcomes were found between Europe and North America. An older population (76.6 vs 66 years; P <.001) with a nonsignificant higher complication rate (16.5% vs 7.7%; P = .2) was observed in Europe vs North America, whereas higher rates of critically ill patients (33.3% vs 3.3%; P <.001) and mortality (26.9% vs 5%; P = .002) were observed in North America vs Europe.Conclusion
CIED procedure rates during known active COVID-19 disease varied greatly, from 0 to 16.2 per 1000 hospitalized COVID-19 patients worldwide. Patients with active COVID-19 infection who underwent CIED implantation had high complication and mortality rates. Operators should take these risks into consideration before proceeding with CIED implantation in active COVID-19 patients.
SUBMITTER: Tovia-Brodie O
PROVIDER: S-EPMC8547796 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature
Tovia-Brodie Oholi O Rav Acha Moshe M Belhassen Bernard B Gasperetti Alessio A Schiavone Marco M Forleo Giovanni Battista GB Guevara-Valdivia Milton E ME Ruiz David Valdeolivar DV Lellouche Nicolas N Hamon David D Castagno Davide D Bellettini Matteo M De Ferrari Gaetano M GM Laredo Mikael M Carvès Jean-Baptiste JB Ignatiuk Barbara B Pasquetto Giampaolo G De Filippo Paolo P Malanchini Giovanni G Pavri Behzad B BB Raphael Craig C Rivetti Luigi L Mantovan Roberto R Chinitz Jason J Harding Melissa M Boriani Giuseppe G Casali Edoardo E Wan Elaine Y EY Biviano Angelo A Macias Carlos C Havranek Stepan S Lazzerini Pietro Enea PE Canu Antonio M AM Zardini Marco M Conte Giulio G Cano Óscar Ó Casella Michela M Rudic Boris B Omelchenko Alexander A Mathuria Nilesh N Upadhyay Gaurav A GA Danon Asaf A Schwartz Arie Lorin AL Maury Philippe P Nakahara Shiro S Goldenberg Gustavo G Schaerli Nicolas N Bereza Sergiy S Auricchio Angelo A Glikson Michael M Michowitz Yoav Y
Heart rhythm 20211026 2
<h4>Background</h4>Cardiac implantable electronic device (CIED) implantation rates as well as the clinical and procedural characteristics and outcomes in patients with known active coronavirus disease 2019 (COVID-19) are unknown.<h4>Objective</h4>The purpose of this study was to gather information regarding CIED procedures during active COVID-19, performed with personal protective equipment, based on an international survey.<h4>Methods</h4>Fifty-three centers from 13 countries across 4 continent ...[more]